Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NASDAQ:NBIX

Overview | Financials
Company Name Neurocrine Biosciences, Inc.
Symbol NBIX
Currency USD
Price 109.07
Market Cap 10,874,660,745
Dividend Yield 0%
52-week-range 105.18 - 157.98
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Kevin C. Gorman Ph.D.
Website https://www.neurocrine.com

An error occurred while fetching data.

About Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive

Related Stocks

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

15.33 USD

Repligen Corporation logo

Repligen Corporation

RGEN

145.37 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

46.35 USD

Bruker Corporation logo

Bruker Corporation

BRKR

44.96 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

2.61 USD

NovoCure Limited logo

NovoCure Limited

NVCR

20.62 USD

Masimo Corporation logo

Masimo Corporation

MASI

167.67 USD

Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc

JAZZ

134.16 USD

Financials

Numbers are in millions USD

Numbers are in millions USD